Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSY

被引:31
作者
Raouf, A
Brown, L
Vrcelj, N
To, K
Kwok, W
Huntsman, D
Eaves, CJ
机构
[1] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
[2] Vancouver Gen Hosp, British Columbia Canc Agcy, Dept Pathol & Lab Med, Genet Pathol Evaluat Ctr, Vancouver, BC, Canada
[3] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[4] Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC, Canada
[5] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2005年 / 97卷 / 17期
关键词
D O I
10.1093/jnci/dji254
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The EMSY gene encodes a protein that interacts with Brca2 and is amplified in some sporadic cases of human breast cancer. To examine whether overexpression of EMSY would mimic the chromosome instability phenotype that is associated with the loss of Brca2 function, we constructed a lentiviral vector (Lenti-EMSY/GFP) that encodes a truncated form of the Emsy protein, including its Brca2-interacting domain, and green fluorescent protein (GFP) and used it to transduce human telomerase-immortalized human breast epithelial (184-hTert) cells, which have a nearly normal karyotype. At passage 5 after transduction, 39 (26%) of 150 EMSY/GFP-transduced metaphase cells contained at least one structural chromosomal abnormality compared with 19 (13%) of 150 GFP-transduced metaphase cells (P=.003, chi-square test); at passage 10, the corresponding frequencies were 42% and 15%, respectively (P<.001). Mitomycin C also produced a severalfold higher frequency of chromosome breaks in the EMSY/GFP-transduced cells than in the control cells. These results support the hypothesis that EMSY overexpression can play a role in the genesis of human breast cancer.
引用
收藏
页码:1302 / 1306
页数:5
相关论文
共 14 条
[1]   Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase [J].
Bryant, HE ;
Schultz, N ;
Thomas, HD ;
Parker, KM ;
Flower, D ;
Lopez, E ;
Kyle, S ;
Meuth, M ;
Curtin, NJ ;
Helleday, T .
NATURE, 2005, 434 (7035) :913-917
[2]   Deletion of Brca2 exon 27 causes hypersensitivity to DNA crosslinks, chromosomal instability, and reduced life span in mice [J].
Donoho, G ;
Brenneman, MA ;
Cui, TX ;
Donoviel, D ;
Vogel, H ;
Goodwin, EH ;
Chen, DJ ;
Hasty, P .
GENES CHROMOSOMES & CANCER, 2003, 36 (04) :317-331
[3]   EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer [J].
Hughes-Davies, L ;
Huntsman, D ;
Ruas, M ;
Fuks, F ;
Bye, J ;
Chin, SF ;
Milner, J ;
Brown, LA ;
Hsu, F ;
Gilks, B ;
Nielsen, T ;
Schulzer, M ;
Chia, S ;
Ragaz, J ;
Cahn, A ;
Linger, L ;
Ozdag, H ;
Cattaneo, E ;
Jordanova, ES ;
Schuuring, E ;
Yu, DS ;
Venkitaraman, A ;
Ponder, B ;
Doherty, A ;
Aparicio, S ;
Bentley, D ;
Theillet, C ;
Ponting, CP ;
Caldas, C ;
Kouzarides, T .
CELL, 2003, 115 (05) :523-535
[4]   High-level β-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells [J].
Imren, S ;
Fabry, ME ;
Westerman, KA ;
Pawliuk, R ;
Tang, P ;
Rosten, PM ;
Nagel, RL ;
Leboulch, P ;
Eaves, CJ ;
Humphries, RK .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (07) :953-962
[5]   A novel BRCA2-binding protein and breast and ovarian tumorigenesis [J].
King, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1252-1253
[6]   EMSY, a BRCA-2 partner in crime [J].
Livingston, DM .
NATURE MEDICINE, 2004, 10 (02) :127-128
[7]   Aberrations of breast cancer susceptibility genes occur early in sporadic breast tumors and in acquisition of breast epithelial immortalization [J].
Meng, ZH ;
Ben, Y ;
Li, Z ;
Chew, K ;
Ljung, BM ;
Lagios, MD ;
Dairkee, SH .
GENES CHROMOSOMES & CANCER, 2004, 41 (03) :214-222
[8]  
Nordling M, 1998, CANCER RES, V58, P1372
[9]   Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome [J].
Rodriguez, C ;
Hughes-Davies, L ;
Vallès, N ;
Orsetti, B ;
Cuny, M ;
Ursule, L ;
Kouzarides, T ;
Theillet, C .
CLINICAL CANCER RESEARCH, 2004, 10 (17) :5785-5791
[10]   Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 [J].
Sharan, SK ;
Morimatsu, M ;
Albrecht, U ;
Lim, DS ;
Regel, E ;
Dinh, C ;
Sands, A ;
Eichele, G ;
Hasty, P ;
Bradley, A .
NATURE, 1997, 386 (6627) :804-810